Susquehanna International Group, LLP Biora Therapeutics, Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Shares

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 14, 2023	SELL	$0.13 - $12.03 $34,218 - $3.17 Million	-263,221 Reduced 55.23%	213,337 $27,000
Q3 2022 Nov 14, 2022	SELL	$0.53 - $13.3 $103,639 - $2.6 Million	-195,547 Reduced 29.09%	476,558 $231,000
Q2 2022 Aug 15, 2022	SELL	$0.56 - $1.22 $158,598 - $345,518	-283,212 Reduced 29.65%	672,105 $470,000
Q1 2022 May 16, 2022	SELL	$1.11 - $2.25 $657,864 - $1.33 Million	-592,671 Reduced 38.29%	955,317 $1.11 Million
Q4 2021 Feb 14, 2022	BUY	$1.35 - $4.89 $1.03 Million - $3.74 Million	764,179 Added 97.5%	1,547,988 $3.24 Million
Q3 2021 Nov 15, 2021	BUY	$0.67 - $3.41 $453,002 - $2.31 Million	676,123 Added 627.87%	783,809 $1.19 Million
Q2 2021 Aug 11, 2021	BUY	$2.11 - $4.93 $188,273 - $439,898	89,229 Added 483.44%	107,686 $384,000
Q1 2021 May 17, 2021	BUY	$3.91 - $7.31 $72,166 - $134,920	18,457 New	18,457 $88,000

Others Institutions Holding BIOR

# of Institutions

2

Shares Held

890

Call Options Held

0

Put Options Held

0

About BIORA THERAPEUTICS, INC.

Ticker BIOR
Exchange NASDAQ
Shares Outstandng 186,623,605
Market Cap $299M
Description
Biora Therapeutics, Inc., a biotechnology company, engages in developing oral biotherapeutics. The company's targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and systemic therapeutics program uses an ing...

More about BIOR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.